Strengthening A Workforce For Innovative Regulatory Science In Therapeutics Development
Download Strengthening A Workforce For Innovative Regulatory Science In Therapeutics Development PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Strengthening A Workforce For Innovative Regulatory Science In Therapeutics Development book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages.
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Author: Institute of Medicine
language: en
Publisher: National Academies Press
Release Date: 2012-05-04
The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Author: Institute of Medicine
language: en
Publisher: National Academies Press
Release Date: 2012-04-04
The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.